Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.

Filippi M, Rocca MA, Pagani E, De Stefano N, Jeffery D, Kappos L, Montalban X, Boyko AN, Comi G; ALLEGRO Study Group.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):851-8. doi: 10.1136/jnnp-2013-306132. Epub 2013 Sep 12.

PMID:
24029546
2.

Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis.

Rocca MA, Valsasina P, Martinelli V, Misci P, Falini A, Comi G, Filippi M.

Neurology. 2012 Oct 2;79(14):1449-57. doi: 10.1212/WNL.0b013e31826d5f10. Epub 2012 Sep 5.

PMID:
22955126
3.

The organization of intrinsic brain activity differs between genders: a resting-state fMRI study in a large cohort of young healthy subjects.

Filippi M, Valsasina P, Misci P, Falini A, Comi G, Rocca MA.

Hum Brain Mapp. 2013 Jun;34(6):1330-43. doi: 10.1002/hbm.21514. Epub 2012 Feb 22.

PMID:
22359372
4.

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.

Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M; FORTE Study Group.

Ann Neurol. 2011 Jan;69(1):75-82. doi: 10.1002/ana.22316.

PMID:
21280077
5.

Default-mode network dysfunction and cognitive impairment in progressive MS.

Rocca MA, Valsasina P, Absinta M, Riccitelli G, Rodegher ME, Misci P, Rossi P, Falini A, Comi G, Filippi M.

Neurology. 2010 Apr 20;74(16):1252-9. doi: 10.1212/WNL.0b013e3181d9ed91. Erratum in: Neurology. 2013 Jan 22;80(4):421.

PMID:
20404306
6.

Preserved brain adaptive properties in patients with benign multiple sclerosis.

Rocca MA, Ceccarelli A, Rodegher M, Misci P, Riccitelli G, Falini A, Comi G, Filippi M.

Neurology. 2010 Jan 12;74(2):142-9. doi: 10.1212/WNL.0b013e3181c91a00.

PMID:
20065249

Supplemental Content

Loading ...
Support Center